Skip to main content

FDA ruling on boosters is expected in days

By The New York Times  
   September 20, 2021

The agency appears likely to authorize a third Pfizer dose for older Americans and those vulnerable to severe COVID-19. It’s preparing to address other big questions in coming weeks, including vaccines for children under 12.

Full story


Get the latest on healthcare leadership in your inbox.